Mesothelioma is a rare and aggressive form of cancer that is caused by exposure to asbestos. While the disease is incurable, recent advances in treatment have helped to improve life expectancy and quality of life for those affected by mesothelioma.
The most common form of treatment for mesothelioma is surgery, which can help to remove tumors and reduce the risk of recurrence. However, surgery is not always feasible, and many patients are unable to undergo the procedure due to the aggressive nature of the disease. For these patients, other treatments such as radiation therapy, chemotherapy, and immunotherapy can be used to help slow the progression of the cancer.
Recently, a new type of treatment known as targeted therapy has emerged as a promising option for mesothelioma patients. Targeted therapy works by targeting specific genes, proteins, or other molecules that are involved in the growth and spread of cancer cells. This type of therapy has been shown to be more effective than traditional chemotherapy, and can often be used in combination with other treatments for improved outcomes.
In addition to targeted therapy, other advances in mesothelioma treatment have included combination therapies, which combine two or more treatments to achieve better results and improved life expectancy. These combinations can include a combination of surgery, radiation, and chemotherapy, or a combination of chemotherapy and immunotherapy.
Finally, recent research has also shown that palliative care can play an important role in improving the quality of life for mesothelioma patients. Palliative care focuses on relieving symptoms and improving quality of life, and can include pain management, emotional support, and other types of therapies.
Overall, advances in mesothelioma treatment have helped to improve life expectancy and quality of life for those affected by the disease. While the disease is still incurable, these advances have helped to give patients more options for managing their condition and living with the disease.